Oral and Maxillofacial Surgery-Heidelberg, published by Springer Heidelberg, stands as a pivotal resource in the fields of oral surgery, otorhinolaryngology, and general surgery. With an ISSN of 1865-1550 and E-ISSN 1865-1569, this peer-reviewed journal has been contributing significant scholarly content since its inception in 2003, with a focus on advancing knowledge and practices through innovative research studies, clinical techniques, and reviews. As a recognized Q2 journal across multiple categories—including Oral Surgery, Otorhinolaryngology, and Surgery—it ranks prominently in Scopus rankings, reflecting its impact and relevance within the medical and dental communities. Despite its non-Open Access model, the journal remains important for researchers and professionals seeking cutting-edge insights and developments in maxillofacial surgery. With a commitment to enhancing clinical practices and patient outcomes, Oral and Maxillofacial Surgery-Heidelberg is an essential resource for those dedicated to advancing the field.

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

Journal of Oral and Maxillofacial Surgery Medicine and Pathology, published by Elsevier Science Inc, serves as a vital resource in the multidisciplinary field of oral and maxillofacial surgery, pathology, and related medical disciplines. With an ISSN of 2212-5558 and an E-ISSN of 2212-5566, this journal plays a pivotal role in advancing knowledge and practices from 2012 to 2024. Recognized for its rigorous peer-review process and quality contributions, it has achieved notable rankings in various categories, including Q3 in Oral Surgery and Q3 in Otorhinolaryngology as of 2023. Although the journal does not currently offer an open access option, it remains a key platform for publishing innovative research that enhances patient care and surgical techniques. This journal is an essential read for researchers, clinicians, and students dedicated to the fields of dentistry, pathology, and surgical medicine, ensuring that they remain at the forefront of community advancements and clinical developments.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a premier journal dedicated to advancing the fields of hematology and oncology. With its ISSN 0889-8588 and E-ISSN 1558-1977, this esteemed publication has been a cornerstone of clinical scholarship since its inception in 1987, providing comprehensive annual updates that bridge the gap between research and clinical practice. Known for its rigorous editorial standards and impactful contributions, the journal holds a respectable Q2 quartile classification in both hematology and oncology as of 2023, ranking it in the 50th percentile among its peers. Although it is not an open-access journal, the content is accessible to institutions and professionals worldwide. As the scope of the journal expands through 2024, it continues to attract an audience of researchers, healthcare professionals, and students who seek to stay informed on the latest advancements, treatment modalities, and groundbreaking studies in the fields of hematology and oncology.

The Archives of Oral Biology, published by Pergamon-Elsevier Science Ltd, is a prestigious journal that has been at the forefront of oral biology research since its inception in 1959. With a focus on advancing knowledge in the fields of cell biology, dentistry, and otorhinolaryngology, this journal serves as a critical platform for disseminating innovative research findings, spanning from fundamental scientific studies to clinical applications. The journal enjoys a respectable impact factor, with notable rankings in various categories, including Q2 in Dentistry and Otorhinolaryngology, making it highly relevant for professionals and researchers alike. Though not open access, the Archives of Oral Biology continues to attract high-quality submissions and remains an influential source of information for the global scientific community, contributing significantly to the understanding of oral health and disease.

BMC CANCER is a prestigious, peer-reviewed journal dedicated to advancing the field of cancer research and oncology since its inception in 2001. Published by BMC, a leading name in open-access publishing, this journal plays a crucial role in providing researchers, professionals, and students with a platform for high-quality scientific discourse. With an impressive impact factor, BMC CANCER is ranked in the Q2 quartile across multiple categories, including Cancer Research, Genetics, and Oncology, reflecting its commitment to impactful research and rigorous peer-review standards. The journal ensures broad accessibility to its content through its Open Access model, allowing findings to reach a global audience without financial barriers. The editorial board consists of recognized experts committed to fostering innovation and collaboration within the cancer research community. Researchers working at the intersection of cancer biology, treatment options, and genetic influences will find BMC CANCER an invaluable resource for sharing their findings and engaging with the latest developments in the field.

Clinical Oral Investigations is a premier journal published by SPRINGER HEIDELBERG, specializing in the multifaceted field of dentistry. Established in 1997, this journal serves as an essential resource for researchers, practitioners, and students alike, offering a platform for the dissemination of high-quality peer-reviewed studies that advance the understanding of oral health and its clinical implications. With an impressive impact factor and ranked in the Q1 category for Dentistry, it occupies a distinguished position among the top-tier publications, reflecting its commitment to excellence as evidenced by a Scopus Rank of #14 out of 132 in General Dentistry, placing it in the 89th percentile. While the journal offers a subscription-based model, it continues to make significant contributions to the field through innovative research articles, reviews, and clinical reports. Located in Heidelberg, Germany, Clinical Oral Investigations is a vital resource for those dedicated to the improvement of oral health and dental practices worldwide.

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY is a premier peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of oral and maxillofacial surgery. With an impressive Q1 ranking in the categories of Oral Surgery, Otorhinolaryngology, and Surgery as of 2023, this journal serves as a vital resource for researchers, clinicians, and students alike, offering cutting-edge research findings, clinical studies, and innovative surgical techniques. The journal covers a wide range of topics within its scope, ensuring that it remains at the forefront of advancements in surgical practice and patient care. Though it operates under a traditional access model, its Impact Factor reflects its significance in the field and its role in disseminating critical knowledge. Established in 1986, the INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY continues to be an essential tool for those dedicated to enhancing therapeutic outcomes and surgical methodologies, solidifying its position as a trusted resource in the ongoing evolution of maxillofacial sciences.